Priority 3 from the Idiopathic Intracranial Hypertension PSP
| UNCERTAINTY: Can new therapies for IIH be developed which are effective, safe, and tolerable and potentially help with weight loss as well as reducing brain pressure? (JLA PSP Priority 3) | |
|---|---|
| Overall ranking | 3 |
| JLA question ID | 0066/3 |
| Explanatory note | Not available for this PSP |
| Evidence |
None identified |
| Health Research Classification System category | Neurological |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | Are further drugs in development for treatment of papilloedema? ~ What are the alternatives to diamox to treat IIH? ~ What are the best evidence based non-medical interventions for treatment of IIH? |
| Submitted by | See data spreadsheet on JLA website |
| PSP information | |
|---|---|
| PSP unique ID | 0066 |
| PSP name | Idiopathic Intracranial Hypertension |
| Total number of uncertainties identified by this PSP. | 48 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 27 April 2018 |